Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GDF15 Ameliorates liver fibrosis by metabolic reprogramming of macrophages to acquire anti-inflammatory properties
Uric acid, urea, and ammonia concentrations in serum and uric acid concentration in excreta as indicators of amino acid utilization in diets for broilers
Patients with established cardiovascular disease should receive a pharmacological treatment intensification with an agent that has demonstrated benefit in cardiovascular safety studies: In patients with pre-existing atherosclerotic cardiovascular disease (ASCVD), a GLP-1 receptor agonist, or SGLT-2 inhibitor with characterized cardiovascular safety should be used
Kinetic distance and kinetic maps from molecular dynamics simulation
US$ 20.14
US$ 25.56
.png)
US$ 20.77
US$ 29.47
US$ 25.36
US$ 27.54
US$ 26.57
